Literature DB >> 21795050

A novel mitochondrial DNA deletion producing progressive external ophthalmoplegia associated with multiple sclerosis.

M Slee1, J Finkemeyer, M Krupa, R Raghupathi, J Gardner, P Blumbergs, M Agzarian, D Thyagarajan.   

Abstract

We report a previously undescribed 7676 base pair mitochondrial (mt)DNA deletion involving genes of complex I, complex IV subunits 2 and 3 (cytochrome oxidase [Cox] II, III), adenosine triphosphatase 8 and 6, cytochrome b and 8 transfer (t)RNA genes producing myopathy and progressive external ophthalmoplegia (PEO) in a 44-year-old right-handed Caucasian man with features of multiple sclerosis (MS). We performed complete mtDNA sequencing and deletion analysis, spectrophotometric analysis of muscle and platelet respiratory chain activity, measurement of platelet mitochondrial membrane potential with the potentiometric dye JC-1 and magnetic resonance spectroscopy (MRS) and MRI studies of normal-appearing and lesional cerebral tissue. The deletion resulted in significant respiratory chain deficiency in muscle and blood and abnormalities of the platelet mitochondrial membrane potential. However, cerebrospinal fluid analysis, magnetic resonance spectroscopy and MRI features suggested inflammatory central nervous system demyelination rather than a primary respiratory chain disorder. We conclude that this novel mtDNA deletion causing myopathy and PEO is associated with severe muscle and platelet cellular energetic abnormalities. Furthermore, clinical and paraclinical features of multiple sclerosis were found. The potential pathomechanistic interaction between mtDNA variation and multiple sclerosis is reviewed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795050     DOI: 10.1016/j.jocn.2011.02.019

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

1.  Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.

Authors:  Lorenzo Gaetani; Andrea Mignarri; Maria Di Gregorio; Paola Sarchielli; Alessandro Malandrini; Elena Cardaioli; Paolo Calabresi; Maria Teresa Dotti; Massimiliano Di Filippo
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

2.  Response to immunotherapy in a patient with adult onset Leigh syndrome and T9176C mtDNA mutation.

Authors:  Miguel Chuquilin; Raghav Govindarajan; Dawn Peck; Esperanza Font-Montgomery
Journal:  Mol Genet Metab Rep       Date:  2016-07-01

Review 3.  Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.

Authors:  Jacqueline M Orian; Claretta S D'Souza; Pece Kocovski; Guy Krippner; Matthew W Hale; Xiaowei Wang; Karlheinz Peter
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

Review 4.  The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence.

Authors:  Allison Hanaford; Simon C Johnson
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.